Learn how life sciences brands can preserve patient data privacy in real-world data and artificial intelligence models
The use of patient real-world health data (RWD) and artificial intelligence (AI) to direct HCP engagement tactics and drive brand growth continues to grow. However, pharma marketers now face the challenge of harnessing the benefits of this data-rich environment without compromising patient privacy.
Join OptimizeRx at MM+M Transform: The New Era of Connectivity, where we’re presenting a case study on “Balancing Patient Data Privacy with RWD Model Effectiveness”. Led by Angelo Campano, our SVP of Market Engagement, we’re sharing how one life science brand leveraged the power of AI- and RWD-driven tools while preserving patient data privacy.
Don’t miss the chance to learn how your life science brand can balance patient privacy with RWD model effectiveness by:
- Building RWD and AI-driven omnichannel strategies that align with current brand lifecycle stage and market position
- Navigating patient data privacy concerns through strategic use of RWD
- Aligning content delivery to the best times and channels for seamless, value-add integration into HCP workflows
Interested in exploring how your brand can take full advantage of the latest advances in RWD, while also adhering to internal patient privacy guidelines? Book a meeting with our team to discover all we can do to maximize your HCP engagement strategies with data and AI-driven solutions.
